Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 16:05 | 11/15/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Cislini Jeff | CA | O | GC | 4 | S.d | -866 | 54.10 | 0 | -16 | 46 | D | |||||||||||||||
11/15/24 16:08 | 11/13/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Kelsey Stephen Michael | CA | O | See Rema | 4 | S.d | -2,731 | 49.95 | 0 | -55 | 269 | D | |||||||||||||||
11/5/24 16:21 | 11/1/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Goldsmith Mark A | CA | DO | See Rema | 4 | S.dm | -6,356 | 52.22 | 0 | -122 | 823 | M | |||||||||||||||
11/4/24 16:05 | 10/31/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Patel Sushil | CA | D | 1 | S.d | -271 | 54.14 | 0 | -5 | 20 | D | ||||||||||||||||
10/15/24 17:31 | 10/11/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Horn Margaret A | CA | O | COO | 2 | S.d | -2,708 | 49.85 | 0 | -54 | 132 | D | |||||||||||||||
10/15/24 17:30 | 10/11/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Anders Jack | CA | O | CFO | 2 | S.d | -602 | 49.18 | 0 | -12 | 99 | D | |||||||||||||||
10/10/24 16:16 | 10/8/24 | RVMD | Health | BioPrd | Biological Products, (No Diag | Weber Barbara | CA | D | 1 | S | -250 | 48.02 | 0 | -5 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |